---

$10.60

-0.5800 ( -5.19% ) 111.2K

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-06-12	Sale	-5190.00	Bermingham Nessan
2024-06-12	Sale	-5190.00	Meyers Rachel
2024-06-12	Sale	-5190.00	Lucchino David L.
2024-06-12	Sale	-5190.00	Behbahani Ali
2024-06-12	Sale	-5190.00	FORMELA JEAN FRANCOIS
2024-06-12	Sale	-5190.00	PEARSON TIMOTHY R
2024-06-04	Sale	-65000.00	Olugemo Olukemi
2024-04-24	Buy	17857.00	Florence Anthony A. Jr.
2024-04-24	Buy	17857.00	Walker Paul Edward
2024-04-24	Sale	-17857.00	Behbahani Ali